About this Research Topic
Thousands of patients have now been treated in prospective trials with SBRT for prostate cancer with excellent long-term efficacy and toxicity, although the acute toxicity might be increased as compared to conventional fractionation. New radiation techniques, fractionation schemes, and devices (such as hydrogels) have been implemented which have resulted in reductions in acute and late toxicity.
The goal of this Research Topic is to provide a single source for clinicians in academics and in private practice.
This Research Topic welcomes manuscripts which cover all aspects of SBRT for the prostate. This involves:
-Retrospective and prospective studies
-Reviews of the literature upon invitation
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: Radiosurgery, node positive, high intermediate risk, low intermediate risk, toxicity, quality of life, simulation
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.